NCT03345316View on ClinicalTrials.gov

Study of FFI-1010 in Pediatric Kidney Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

November 1, 2019

Study Completion Date

November 1, 2019

Conditions
Children Under 18 Years Old With Kidney Disease
Interventions
DRUG

FFI-1010

Intravenous single dosing

Trial Locations (1)

Unknown

Fuji Yakuhin Investigational sites, Tokyo

Sponsors
All Listed Sponsors
lead

Fuji Yakuhin Co., Ltd.

INDUSTRY